healthŌme and GalenusRx Forge Strategic Partnership to Launch Genomics-based Personalized Medication Safety Program
June 3, 2024

Hospitalogy Features Galenus Rx as Innovative Startup

Hospitalogy’s May 2024 newsletter highlights Galenus Rx in its Innovative Startup section. Galenus Rx addresses the significant issue of unoptimized medication regimens, which cost billions in preventable adverse drug events and excess morbidity. Their platform, APPRAISE, offers advanced medication safety assessments, analyzing drug interactions down to the DNA level to provide actionable insights for safer and more effective treatment. This innovative approach aims to improve patient outcomes and reduce healthcare costs.

Click Here for the Full Article

Other Posts

February 17, 2025

FERNANDINA BEACH, FL – Precision medication safety organization GalenusRx welcomes Stephanie Davis, a top-ranked healthcare equity research analyst, to its…

February 11, 2025

FERNANDINA BEACH, FL – Dr. Mark A. Munger, Professor of Pharmacotherapy and Adjunct Professor of Internal Medicine at the University…

February 4, 2025

Bringing Decades of Value-Based Care Insights & Innovation Fernandina Beach, FL – February 4th, 2025 – GalenusRx, a leader in precision…

January 25, 2025

In the November 30, 2024, Wall Street Journal article, “Why Does America’s Falling Epidemic Keep Getting Worse?” author Peter Funt…

January 18, 2025

Jacksonville, FL, January 15, 2025 — The Florida Association of ACOs (FLAACOs) announced that GalenusRx, a leader in precision medication…

July 12, 2024

Galenus Rx is thrilled to announce that Larry Lesko, the Chair of our newly formed Scientific Advisory Board and a…